United States Workplace Stress Management Markets Report 2022-2027 Featuring Prominent Vendors – ComPsych, LabCorp, CVS Health (ActiveHealth), CuraLinc Healthcare, & Marino Wellness – Yahoo Finance

Share Article

DUBLIN, Jan. 26, 2022 /PRNewswire/ — The "U.S. Workplace Stress Management Market – Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
Employees are going through epidemic levels of stress due to the COVID-19 pandemic and depression that is a direct result of always-on responsibility, dwindled workforce, and toxic office environment and culture. This has warranted the need for workplace stress management programs to boost sustainable development and a thriving standard of high-quality life which is fueling the stress management market.
The pandemic aggravated stress, driving demand for therapeutic intervention and demonstrating the need for equitable and accessible mental health benefits. The disaster distress helpline, a federal crisis hotline operated by the substance Abuse and Mental Health Services Administration, has witnessed an increase of over 300% in calls since February 2020.
The U.S. workplace stress management market is particularly growing with the presence of vendors such as ComPsysch, LabCorp, ActiveHealth, CuraLinc Healthcare, and Marino Wellness, among others offering services at workplaces.
SEGMENTATION ANALYSIS
Employers can start emphasizing mental health by ensuring that employees have access to mental health advantages involving an employee assistance program (EAP). EAPs are helpful as they can offer referrals to mental health professionals and other services while upholding strict standards of confidentiality.
Yoga and meditation offer extensive mental, physical, and emotional relaxation. It directs the conscious level of a person in an optimistic direction and transforms the mind. The yoga and meditation segment will grow at the highest CAGR.
The stress level assessment of employees at the workplace gains vital importance to enhance the efficacy of employees. Workplace stress assessment helps the employers evaluate and identify any issues or factors causing work-related stress to the employees.
GEOGRAPHICAL ANALYSIS
The leading drivers for health and well-being programs in the US are the need to manage workplace stressors such as long working hours, quality of work-life balance, rising competition at the workplace, and others. Organization profits that recorded an uptick after a long period of sluggish growth fuel the adoption of stress management programs.
The US people pay a greater price from workplace stressors, in terms of health costs and perhaps mortality compared to OECD countries in Europe. Expansion of health insurance coverage, increasing awareness about workplace stress costs, and adopting family-friendly work policies more widely, could considerably benefit US workers.
VENDOR ANALYSIS
The market has witnessed the entry of a lot of external players, such as in-house services by large businesses and other entities in the health and fitness space that offer membership discounts to drive up their share in the market.
Vendors compete in terms of aftersales services, brand value, customization ability, price, skilled workforce, and technological capability as well. Most of these vendors offer stress management services and wellness portals. Vendors also tend to tie up with technology companies to develop stress management programs.
SNIPPETS
Employees are going through epidemic levels of stress due to the COVID-19 pandemic and depression that is a direct result of always-on responsibility, dwindled workforce, and toxic office environment and culture. This has warranted the need for workplace stress management programs to boost sustainable development and a thriving standard of high-quality life which is fueling the stress management market.
Vendors should integrate platforms to include health assessment and performance tracking of the employees. Few vendors in the market have platforms in the form of applications such as Runkeeper, which helps employers analyze employee performance and assists them in taking the proper initiative to enhance their productivity.
The company should understand the need of employees and design stress management programs as per the changing dynamics. The programs should be designed in accordance with the work from home era triggered by the COVID-19 pandemic.
KEY MARKET DRIVERS
Rising Attention to Occupational Safety and Health Regulations
Employee Turnover Rate
Stress Encountered by Women is Higher Due to COVID-19 Pandemic
Increasing Use of Artificial Intelligence
Rise in Number of Working Hours
Increasing Awareness of Stress Management
Changing Needs of Employees
PROMINENT VENDORS
ComPsych
LabCorp
CVS Health (ActiveHealth)
CuraLinc Healthcare
Marino Wellness
OTHER PROMINENT VENDORS
Asset Health
Fitbit
Wellsource
Sol Wellness
Vitality
Virgin Pulse
Active Wellness
Aduro
Alyfe Wellbeing Strategies
Beacon Health Options
Castlight
Ceridian
Corporate Fitness Works
HealthCheck360
Integrated Wellness Partners
Healthfitness
Provant Health Solutions
Lifestart
Exos
Karelia Health
Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.1.1 Causes Of Stress
7.1.2 Technological Advancements
7.1.3 Cost Of Stress To US Corporates
7.1.4 Stressed Workers In The US Automotive Industry
7.1.5 Model Of The Stress Process
7.1.6 Stress Management Techniques
7.1.7 Income Analysis In The US
7.1.8 Historical Data
7.2 Impact Of Covid-19

8 Market Opportunities & Trends
8.1 Rising Attention Toward Occupational Safety And Health Regulations
8.2 Employee Turnover Rate
8.3 Stress Encountered By Women Being Higher Due To Covid-19
8.4 Increasing Use Of Artificial Intelligence

9 Market Growth Enablers
9.1 Rise In The Number Of Working Hours
9.2 Increasing Awareness Of Stress Management
9.3 Changing Needs Of Employees

10 Market Restraints
10.1 Increased Sense Of Anxiety
10.2 Low Participation Of Employees
10.3 Barriers And Stigma In Workplace Stress Management

11 Market Landscape
11.1 Market Size & Forecast
11.2 Five Forces Analysis

12 Stress Management Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Mental
12.4 Physical

13 Service
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Stress Assessment
13.4 Yoga & Meditation
13.5 Progress Tracking Metrics
13.6 Resilience Training
13.7 Others

14 Delivery Mode
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Personal Fitness Trainers
14.4 Meditation Specialists
14.5 Individual Counselors
14.6 Others

15 Location
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 On-Premise
15.4 Off-Premise

16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Large Private Sector
16.4 Medium Private Sector
16.5 Public Sector
16.6 Small Private Sector
16.7 Non-Profit Organizations
16.8 Others

17 Region
17.1 Market Snapshot & Growth Engine
17.2 Region Overview
For more information about this report visit https://www.researchandmarkets.com/r/g2smm5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/united-states-workplace-stress-management-markets-report-2022-2027-featuring-prominent-vendors—compsych-labcorp-cvs-health-activehealth-curalinc-healthcare–marino-wellness-301468618.html
SOURCE Research and Markets
TG Therapeutics Inc's (NASDAQ: TGTX) CEO Michael Weiss said that the FDA has placed a partial clinical hold on some combination candidate studies for leukemia and lymphoma. Speaking at the B. Riley Securities' 2022 Virtual Oncology Investor Conference, Weiss disclosed that FDA placed partial holds on studies of the U2 combination UKONIQ (umbralisib) and ublituximab for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). Weiss noted that the updated overall survival (OS) prelimin
The road to FDA approval can be long, and in the case of COVID-19 vaccines, there is no time for delays and no room for error. One company that has come to understand this very well is Novavax (NASDAQ: NVAX). Since 2020, the company has been developing a vaccine to help prevent and fight the impact of COVID-19.
Let's take a quick look at how Vaxart's project might be a game-changer. There are two things in Vaxart's favor regarding the chances of its pill being a pandemic-ending tool. Unlike the jabs produced by Pfizer and Moderna, Vaxart's oral tablet doesn't require skilled staff or syringes to administer, nor does it require specialized refrigerators to keep the vaccine stable.
(Bloomberg) — Wall Streeters shuddered as the news broke last year that U.S. regulators were examining whether bank employees were using personal phones to text about business with each other and clients — a rule that just about everyone seemed to be breaking.Most Read from BloombergApple to Rival Square by Turning iPhones Into Payment TerminalsTech Giants Drag Down Stocks While Dollar Jumps: Markets WrapPowell Backs March Liftoff, Won’t Rule Out Hike Every MeetingA Nor’easter Approaching New
Alphabet Inc's Google on Thursday increased the amount of time employees around the world can take off for vacation or caring for newborns and seriously ill loved ones. Google has long been known as a global trailblazer in workplace benefits. Employees also have grown frustrated during the pandemic about long work hours, without being able to enjoy free meals and other Google office perks.
Short-staffed employers are pressuring workers to stay on the job while feeling sick or with COVID-19. CDC guidance and testing disparities aren't helping.
In a statement given to Reuters, the company said that it will close its DRAM Engineering Group from its Shanghai Design Center over the next year, with completion expected by December 2022. Micron makes NAND memory chips that serve the data storage market as well as DRAM chips that are widely used in data centres, personal computers and other devices. In 2018, the U.S. Department of Justice indicted Taiwan-based chip maker United Microelectronics Corp (UMC) and China's Fujian Jinhua Integrated Circuit Co Ltd, alleging the companies conspired to steal trade secrets from Micron.
(Bloomberg) — Oil palm planters in Malaysia are confronting a hard truth — behind the red-hot rally in prices are thousands of jobs that nobody wants. Most Read from BloombergPowell Backs March Liftoff, Won’t Rule Out Hike Every MeetingA Nor’easter Approaching New York Risks Becoming a Bomb CycloneApple to Rival Square by Turning iPhones Into Payment TerminalsStocks Halt Rally as Bond Yields Spike After Fed: Markets WrapAstronomers Spot Never-Before Seen Object at 4,000 Light-Years AwayWhile h
Natural-gas prices rallied Thursday, with traders shocked by a more than 46% jump in prices at the settlement, as the front-month February futures contract expired at the end of the trading session. Natural gas for February delivery settled at $6.265 per million British thermal units, up $1.99, or 46.5% on the New York Mercantile Exchange, according to Dow Jones Market Data – the largest one-day percentage move on record and highest finish since October. The 219 billion-cubic-foot weekly fall in
These two clinical-stage biotechs have major upcoming catalysts that could catapult their shares higher.
Moderna Chief Medical Officer Dr. Paul Burton joins Yahoo Finance Live to discuss the protection of a booster shot against Omicron and the need to improve vaccination rates.
A federal judge said Amazon.com Inc and its Whole Foods unit can be sued over the refusal to hire a convicted murderer who claimed to be rehabilitated after nearly 23 years in prison. In a Wednesday night decision, U.S. District Judge Valerie Caproni in Manhattan said Henry Franklin could pursue a proposed class action after being turned down for a grocery delivery job at Cornucopia Logistics, which serves Amazon and Whole Foods. Amazon determined after a background check that Franklin had lied on his April 2019 job application by answering "no" when asked if he had a criminal record.
There’s plenty of money to be made from oil before the dirty fuel is no longer needed, just as there has been from cigarettes. This is the fifth Streetwise column in a series on sustainable investing.
The tax-free deal on the Roth IRA may seem too good to be true, but rest assured that there are at least five good reasons for it to stay that way.
Talk of $100-a-barrel oil has intensified in recent days, but triple-digit prices may pose a disadvantage for major oil-producing nations that are set to meet next week to decide the best course of action on production levels.
New York’s attorney general wants to put a stop to former President Donald Trump's attempted end-run around a yearslong civil investigation into his business practices, asking a judge Wednesday to dismiss his lawsuit aimed at halting the probe.
Earlier this month, the European Commission gave Lumykras the go-ahead as a treatment for lung cancer.
(Bloomberg) — U.S. shale executives have finally achieved something that eluded the industry for more than a decade: the ability to turn over billions of dollars in dividends to shareholders while at the same time boosting production to tap into surging global oil demand.Most Read from BloombergApple to Rival Square by Turning iPhones Into Payment TerminalsPowell Backs March Liftoff, Won’t Rule Out Hike Every MeetingNasdaq 100’s Gains Evaporate as Tesla Plunges 8%: Markets WrapA Nor’easter Appr
A tech company that provides secure file sharing services has reached an $8.1 million settlement with a large group of people, including millions of Kroger Co. customers and employees, who were impacted by a data breach last year.
Vaccinex Inc (NASDAQ: VCNX) shares are gaining after the Company reported interim response data in the Phase Ib segment of the KEYNOTE-B84 study. The trial is evaluating Vaccinex's pepinemab combined with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Among the three patients enrolled in the safety segment of the study, two patients experienced a complete response (CR). Biomarker analysis revealed that tumors in

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness